Listing Particulars

GlaxoSmithKline PLC 13 May 2005 FORMAL NOTICE FOR SPECIALIST SECURITIES PUBLICATION DATE: 13th May 2005 Application has been made to the UK Listing Authority for the following securities to be admitted to the Official List. DETAILS OF ISSUE: £5,000,000,000 Euro Medium Term Note Programme ISSUER: GlaxoSmithKline plc GlaxoSmithKline Capital GlaxoSmithKline GlaxoSmithKline Inc. Capital plc Capital Kabushiki Kaisha INCORPORATED IN: GlaxoSmithKline plc and GlaxoSmithKline Capital plc were incorporated in England under the Companies Act 1985, GlaxoSmithKline Capital Inc, was incorporated under the laws of the State of Delaware and GlaxoSmithKline Capital Kabushiki Kaisha was incorporated in Japan. GUARANTOR: GlaxoSmithKline plc INCORPORATED IN: Incorporated in England under the Companies Act 1985 Particulars relating to the issue may be obtained during usual business hours for fourteen days from the date of this formal notice from: GlaxoSmithKline Capital plc Citibank, N.A. 980 Great West Road 5 Carmelite Street Brentford London Middlesex EC4Y 0PA TW8 9GS In addition, a copy of the Particulars is available for inspection at the Document Viewing Facility at the Financial Services Authority, 25 The North Colonnade, London E14 5HS. This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100

Latest directors dealings